By Stephen Nakrosis Mirati Therapeutics said on Friday the U.K.'s Medicines and Healthcare Products Regulatory Agency gave conditional marketing approval for.
By Sabela Ojea Shares of Coherus BioSciences climbed 12% to $2.96 in after-hours trading after the company said the Food and Drug Administration approved.
By Colin Kellaher Pfizer has won expanded approval from the U.S. Food and Drug Administration of the combination of its Braftovi and Mektovi drugs for.
By Colin Kellaher Merck & Co. on Tuesday said a Phase 3 study of its Keytruda cancer drug met the second of its dual primary endpoints as a perioperative.